Mesoblast reported 1.56M in Sales Revenues for its fiscal semester ending in December of 2024.


Sales Change Date
Avita Medical AUD 18.41M 7.89M Dec/2024
Clinuvel Pharmaceuticals AUD 55.92M 23.66M Jun/2024
Cochlear AUD 1.17B 34.7M Dec/2024
CSL USD 8.21B 1.47B Dec/2024
Pacific Edge NZD 10.96M 5.32M Sep/2024
Paradigm Biopharmaceuticals AUD 433.66K 4.81M Dec/2024
PYC Therapeutics AUD 12.69M 6.11M Dec/2024
Ramsay Health Care AUD 9.29B 700M Dec/2025
Sonic Healthcare AUD 4.98B 311M Jun/2025
Starpharma Holdings AUD 2.43M 1.56M Dec/2024
Telix Pharmaceuticals AUD 309.72M 109.32M Jun/2025